> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Revision on BLA Procedures
- URL: https://www.fdaweb.com/info-collection-revision-on-bla-procedures/
- Published: 2023-08-15T12:00:00.000Z
- Updated: 2026-09-14T18:50:39.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155102

*Federal Register* notice: FDA has submitted to OMB an information collection revision entitled “Biologics License Applications (BLAs) Procedures and Requirements.” The collection supports agency statutory and regulatory requirements that govern biologics product licensing. It is being revised to support a CBER standards recognition program for regenerative medicine therapies that is designed to assist with development and assessment of such products. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-08-15/pdf/2023-17460.pdf?ref=fdaweb.com).